关键信息
-
基因名
asa1
- 应用
-
别名
asa1；OASA1；Anthranilate synthase alpha subunit 1. chloroplastic
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P47998
-
表达区间
2-322aa
-
氨基酸序列
ASRIAKDVT ELIGNTPLVY LNNVAEGCVG RVAAKLEMME PCSSVKDRIG FSMISDAEKK GLIKPGESVL IEPTSGNTGV GLAFTAAAKG YKLIITMPAS MSTERRIILL AFGVELVLTD PAKGMKGAIA KAEEILAKTP NGYMLQQFEN PANPKIHYET TGPEIWKGTG GKIDGFVSGI GTGGTITGAG KYLKEQNANV KLYGVEPVES AILSGGKPGP HKIQGIGAGF IPSVLNVDLI DEVVQVSSDE SIDMARQLAL KEGLLVGISS GAAAAAAIKL AQRPENAGKL FVAIFPSFGE RYLSTVLFDA TRKEAEAMTF EA
-
分子量
33.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
Asa1 recombinant protein is a significant subject of study due to its potential applications in various fields, including molecular biology, biotechnology, and medicine. Asa1 is a protein associated with distinct biological functions, such as stress response and cellular regulation in certain organisms. Research into its recombinant form allows for deeper insights into its structural and functional properties, which can be leveraged for protein engineering and therapeutic development. The ability to produce Asa1 in a recombinant fashion facilitates large-scale studies, enabling researchers to analyze its interactions, mechanisms of action, and potential as a biomarker or therapeutic target. Furthermore, as a model for understanding protein expression systems, Asa1's study contributes to broader advances in recombinant protein technology, which holds significant implications for vaccine development, enzyme production, and disease treatment strategies. Thus, the ongoing investigation into Asa1 recombinant protein encompasses not only basic scientific inquiry but also practical applications that could enhance our understanding of cellular processes and lead to innovative solutions in healthcare and industry.
